Nutritional interventions for mitochondrial OXPHOS deficiencies: mechanisms and model systems
Tricompartmental microcarriers with controlled release for efficient management of Parkinsons disease
- Drugs.com, accessed April 21, 2025, Tufts Experts Weigh in on New Generation of Weight Loss Medications | School of Medicine, accessed April 21, 2025, GLP-1 Drugs and Muscle Loss: What Patients Need to Know - Highbar Physical Therapy, accessed April 21, 2025, Muscle loss with Ozempic and similar drugs - FSHD Society, accessed April 21, 2025, Ozempic Can Cause Major Loss of Muscle Mass and Reduce Bone Density - Healthline, accessed April 21, 2025, The Importance of Muscle Maintenance During Weight Loss, accessed April 21, 2025, Body Recomposition: Building Muscle While Losing Weight - WebMD, accessed April 21, 2025, Diabetes drugs and weight loss - Mayo Clinic, accessed April 21, 2025, What is a GLP-1 agonist, and how does it work
If glucose goals are not achieved with basal insulins at doses higher than 0.5U/kg in 34months, treatment intensification should be considered
T-HL: Conceptualization, Methodology, Writing review & editing